Torii Pharmaceutical Co., Ltd. (TYO:4551)
Japan
· Delayed Price · Currency is JPY 4,395.00
-55.00 (-1.24%)
Mar 10, 2025, 3:30 PM JST
Torii Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 7, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 126,188 | 132,364 | 99,800 | 81,805 | 80,794 | 90,395 | Upgrade
|
| Market Cap Growth | 32.63% | 32.63% | 22.00% | 1.25% | -10.62% | 5.32% | Upgrade
|
| Enterprise Value | 83,319 | 92,377 | 55,050 | 22,639 | 14,181 | 18,444 | Upgrade
|
| Last Close Price | 4495.00 | 4715.00 | 3450.85 | 2735.89 | 2611.31 | 2868.74 | Upgrade
|
| PE Ratio | 25.06 | 26.25 | 24.23 | 20.74 | 23.95 | 25.86 | Upgrade
|
| PS Ratio | 2.09 | 2.19 | 1.83 | 1.67 | 1.72 | 2.17 | Upgrade
|
| PB Ratio | 1.04 | 1.09 | 0.83 | 0.69 | 0.69 | 0.79 | Upgrade
|
| P/TBV Ratio | 1.09 | 1.09 | 0.83 | 0.69 | 0.69 | 0.79 | Upgrade
|
| P/FCF Ratio | 36.19 | 37.96 | - | 35.57 | - | - | Upgrade
|
| P/OCF Ratio | 36.37 | 36.37 | - | 33.80 | - | - | Upgrade
|
| EV/Sales Ratio | 1.38 | 1.53 | 1.01 | 0.46 | 0.30 | 0.44 | Upgrade
|
| EV/EBITDA Ratio | 11.56 | 12.82 | 10.02 | 3.78 | 2.80 | 3.47 | Upgrade
|
| EV/EBIT Ratio | 12.25 | 13.59 | 10.93 | 4.09 | 3.05 | 3.89 | Upgrade
|
| EV/FCF Ratio | 23.89 | 26.49 | - | 9.84 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | 0.04 | 0.09 | 0.10 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.12 | 0.12 | - | 0.23 | - | - | Upgrade
|
| Asset Turnover | 0.44 | 0.44 | 0.41 | 0.37 | 0.37 | 0.31 | Upgrade
|
| Inventory Turnover | 2.89 | 2.89 | 3.23 | 2.88 | 2.85 | 2.72 | Upgrade
|
| Quick Ratio | 4.10 | 4.10 | 5.80 | 6.19 | 7.08 | 9.41 | Upgrade
|
| Current Ratio | 5.21 | 5.21 | 7.05 | 6.93 | 7.86 | 10.23 | Upgrade
|
| Return on Equity (ROE) | 4.17% | 4.17% | 3.44% | 3.34% | 2.91% | 3.06% | Upgrade
|
| Return on Assets (ROA) | 3.10% | 3.10% | 2.36% | 2.62% | 2.27% | 2.23% | Upgrade
|
| Return on Capital (ROIC) | 3.51% | 3.51% | 2.62% | 2.92% | 2.50% | 2.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.55% | 5.55% | 4.16% | 4.60% | 3.93% | 4.07% | Upgrade
|
| Earnings Yield | 4.00% | 3.81% | 4.13% | 4.82% | 4.18% | 3.87% | Upgrade
|
| FCF Yield | 2.76% | 2.63% | -3.29% | 2.81% | -0.38% | -4.13% | Upgrade
|
| Dividend Yield | 2.73% | - | - | - | - | - | Upgrade
|
| Payout Ratio | 72.47% | 72.47% | 85.94% | 34.18% | 39.95% | 38.54% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -0.02% | -0.02% | -0.02% | -0.03% | -0.04% | Upgrade
|
| Total Shareholder Return | 2.71% | -0.02% | -0.02% | -0.02% | -0.03% | -0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.